Rchr
J-GLOBAL ID：202401009991478984
Update date: Jul. 12, 2024
Hanada Kenji
ハナダケンジ 賢二 | Hanada Kenji
Affiliation and department：
Research keywords (2)：
Coronary spastic angina
, βアレスチン
Research theme for competitive and other funds (4)：
- 2022 - 2025 肺高血圧症における新たな機序の解明:エンドセリン受容体におけるβアレスチンの役割
- 2022 - 2025 カルシウム感受性亢進に着目した冠攣縮性狭心症の新規病態の解明と治療法の確立
- 2019 - 2022 Role of calcium/calmodulin-dependent protein kinase II and development of new treatment strategy for coronary spastic angina
- 2018 - 2021 A new mechanism of coronary spastic angina: Possible role of beta-arrestin
Papers (28)：
-
Takanobu Soma, Hiroaki Yokoyama, Kazumasa Saito, Shota Washima, Michiko Tsushima, Maiko Senoo, Hiroaki Ichikawa, Fumie Nishizaki, Shuji Shibutani, Kenji Hanada, et al. Serial longitudinal changes of coronary calcified plaques with clear outer borders under intensive lipid management: insights from optical coherence tomography. Heart and vessels. 2024. 39. 5. 373-381
-
Kenji Hanada, Hirofumi Tomita. Prognostic Impact of Acute Myocardial Infarction-Related Ventricular Tachyarrhythmia in the Current Era - Reply. Circulation journal : official journal of the Japanese Circulation Society. 2024. 88. 2. 262-262
-
Kenji Hanada, Takahiko Kinjo, Hiroaki Yokoyama, Michiko Tsushima, Maiko Senoo, Hiroaki Ichikawa, Fumie Nishizaki, Shuji Shibutani, Takashi Yokota, Ken Okumura, et al. Incidence, Predictors, and Outcome Associated With Ventricular Tachycardia or Fibrillation in Patients Undergoing Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction. Circulation journal : official journal of the Japanese Circulation Society. 2023
-
Kenji Hanada, Shingo Sasaki, Maiko Seno, Yoshihiro Kimura, Hiroaki Ichikawa, Fumie Nishizaki, Hiroaki Yokoyama, Takashi Yokota, Ken Okumura, Hirofumi Tomita. Reduced Left Ventricular Ejection Fraction Is a Risk for Sudden Cardiac Death in the Early Period After Hospital Discharge in Patients With Acute Myocardial Infarction. Circulation journal : official journal of the Japanese Circulation Society. 2022. 86. 10. 1490-1498
-
Masato Narita, Kenji Hanada, Yosuke Kawamura, Hiroaki Ichikawa, Shuntaro Sakai, Yoshikazu Yokono, Maiko Senoo, Noritomo Narita, Michiko Shimada, Tomohiro Osanai, et al. Rivaroxaban attenuates cardiac hypertrophy by inhibiting protease-activated receptor-2 signaling in renin-overexpressing hypertensive mice. Hypertension research : official journal of the Japanese Society of Hypertension. 2021. 44. 10. 1261-1273
ｍore...
Return to Previous Page
